Cassini Technologies B.V., a global pioneer in ophthalmic solutions, today announces that the seamless and smart connectivity between the Cassini Ambient and the AVENTA Surgical Microscope is currently in development for digital data management, surgical planning, visualization and guidance.
Cassini Technologies B.V., a global pioneer in ophthalmic solutions, today announces that Cassini Ambient diagnostic data is now available for image guidance on the Beyeonics One™ ophthalmic exoscope for 3D IOL alignment procedures.
Masmei Ginting promoted to Vice President of Research and Development and Ernst Serfontein promoted to Chief Product Officer.
Cassini, a pioneer in refractive cataract surgery solutions and advanced corneal diagnostics, announced today that it has appointed Mark Maire as Chief Executive Officer of Cassini Technologies B.V. Mark will succeed current CEO and co-founder Joris Vogels, who will continue to stay closely involved as Strategic Advisor to the company.
Cassini Technologies BV, a global pioneer in corneal diagnostics today announces that the seamless compatibility between the latest cOS 6.0 software for the CATALYS Precision Laser System and the Cassini Ambient is ready for market launch.
Cassini, a pioneer in the development of corneal diagnostic solutions, announced the appointment of Jan Egberts to the Board of Directors.
Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it will reveal its New Cassini device at the 37th Congress of European Society of Cataract and Refractive Surgeons in Paris.
Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has appointed Joris Vogels to Chief Executive Officer of Cassini Technologies B.V. Joris will succeed current CEO Jeroen Cammeraat, who will assume the role of Chairman of the Board.
Cassini® to present latest developments at the Ophthalmology Innovation Summit (OIS@ASCRS) in Washington DC
Mark Packer MD, Chief Medical Officer, will highlight Cassini as core technology in today’s refractive cataract surgery ecosystem. Cassini enables seamless integration of clinic and operating suite, from preoperative diagnostics through visualization, iris registration and laser applications to postoperative data analysis.
Cassini, a pioneer in the development of corneal diagnostic solutions, announced today that it has closed a Series A financing round with venture capital fund Innovation Industries. The injection of capital will accelerate the development and successful commercialization of Cassini, a diagnostic platform for premium refractive cataract surgery procedures.